InvestorsHub Logo
Followers 24
Posts 690
Boards Moderated 0
Alias Born 09/27/2010

Re: blue_skies post# 2138

Wednesday, 02/14/2018 3:38:30 PM

Wednesday, February 14, 2018 3:38:30 PM

Post# of 2463
absolutely agree on where and what the upside potential is. If it was back at $0.40 I'd buy as I can see they are making $0.02/year right now and if they can continue to grow they can maybe make what $0.04/share in 2 years if they can grow revenues and not grow expenses. I started following this in last 2013 and 2014 and they did the same thing growing sales while generally maintaining margins but they could never keep the SG&A expenses in line growing faster than revenue gains.

This feels like a step up in revenue after flatlining for 2 years which is good but I want them to show that they can grow revenues without growing expense. I was excited by Q2 when expenses were down sequentially by quite a bit becuase I felt if they could do that they could be a good story even if the growth doesn't come.

If I buy today I am buying in to the upside story and I'm probably early. I've been burned by that too many times. Now, I'll wait. If they get business for other drug applications thene a new release will push it up 50% overnight and most people will say damn I missed my chance. That is when I will buy. Sure I may have missed the first 100% but my odds of it being right are much better.